A Novel Animal Model of Parkinson’s Disease Using Optogenetics: Representation of Various Disease Stages by Modulating the Illumination Parameter

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Stereotactic and Functional Neurosurgery

• Publication date

  2018-02-14

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1159/000486644PMID 29444523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of Parkinson's disease

  2018cited by this paper
• Optogenetic approaches to evaluate striatal function in animal models of Parkinson disease

  2016cited by this paper
• Optogenetic Inhibition of the Subthalamic Nucleus Reduces Levodopa-Induced Dyskinesias in a Rat Model of Parkinson's Disease

  2016cited by this paper
• Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.

  2015cited by this paper
• Optogenetic control of nerve growth

  2015cited by this paper
• Natural photoreceptors and their application to synthetic biology.

  2015cited by this paper
• Animal models of Parkinson's disease: An updated overview.

  2015cited by this paper
• Optogenetic control of intracellular signaling pathways.

  2015cited by this paper
• Optogenetic inactivation of the subthalamic nucleus improves forelimb akinesia in a rat model of Parkinson disease.

  2014cited by this paper
• Illuminating cell signalling with optogenetic tools

  2014cited by this paper
• Noninvasive optical inhibition with a red-shifted microbial rhodopsin

  2014cited by this paper
• Spatio‐temporally precise activation of engineered receptor tyrosine kinases by light

  2014cited by this paper
• Optogenetic control of phosphoinositide metabolism

  2012cited by this paper
• Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.

  2012cited by this paper
• Genetics of Parkinson's disease.

  2012cited by this paper
• Update on Genetics of Parkinsonism

  2012cited by this paper
• Milestones in PD genetics

  2011cited by this paper
• Tyrosine hydroxylase and regulation of dopamine synthesis.

  2011cited by this paper
• Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons

  2011cited by this paper
• Parkinson’s disease mouse models in translational research

  2011cited by this paper
• A history of optogenetics: the development of tools for controlling brain circuits with light

  2011cited by this paper
• Genetic animal models of Parkinson's disease.

  2010cited by this paper
• Striatal transplantation in a rodent model of multiple system atrophy: Effects on L‐Dopa response

  2009cited by this paper
• Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system.

  2008cited by this paper
• Active and passive immunotherapy for neurodegenerative disorders.

  2008cited by this paper
• SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.

  2008cited by this paper
• Multiple-Color Optical Activation, Silencing, and Desynchronization of Neural Activity, with Single-Spike Temporal Resolution

  2007cited by this paper
• Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias

  2007cited by this paper
• Multimodal fast optical interrogation of neural circuitry

  2007cited by this paper
• Millisecond-timescale, genetically targeted optical control of neural activity

  2005cited by this paper
• Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP

  2004cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Ubiquitination of soluble and membrane-bound tyrosine hydroxylase and degradation of the soluble form.

  2002cited by this paper
• Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates

  1999cited by this paper
• Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease.

  1997cited by this paper
• 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat

  1996cited by this paper
• Involvement of Intracellular or Extracellular Calcium in Activation of Tyrosine Hydroxylase Gene Expression in PC12 Cells

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.

  1996cited by this paper
• Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.

  1995cited by this paper
• The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.

  1994cited by this paper
• Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

  1994cited by this paper
• Regulation of tyrosine hydroxylase gene expression in depolarized non-transformed bovine adrenal medullary cells: second messenger systems and promoter mechanisms.

  1994cited by this paper
• Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats.

  1991cited by this paper
• Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum.

  1991cited by this paper
• Differential effect of functional olfactory bulb deafferentation on tyrosine hydroxylase and glutamic acid decarboxylase messenger RNA levels in rodent juxtaglomerular neurons

  1991cited by this paper
• pH‐dependent release of catecholamines from tyrosine hydroxylase and the effect of phosphorylation of Ser‐40

  1990cited by this paper
• A 6-hydroxydopamine-induced selective parkinsonian rat model.

  1989cited by this paper
• Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys.

  1988cited by this paper
• Depolarizing stimuli increase tyrosine hydroxylase in the mouse locus coeruleus in culture.

  1986cited by this paper
• The long-term regulation of ganglionic tyrosine hydroxylase by preganglionic nerve activity.

  1980cited by this paper
• The long-term regulation of ganglionic tyrosine hydroxylase by preganglionic nerve activity.

  1980cited by this paper
• Mechanisms of action of 6-hydroxydopamine.

  1975cited by this paper
• Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra.

  1969cited by this paper

• Optogenetic regulation of chloride ions in reactive astrocytes may mitigate Parkinson’s disease pathology

  2025influential citation
• Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo.

  2024cites this paper
• Optogenetics in chronic neurodegenerative diseases, controlling the brain with light: A systematic review

  2024cites this paper
• DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms

  2023cites this paper
• Optical EUS Activation to Relax Sensitized Micturition Response

  2023cites this paper
• Study on the Regulation Effect of Optogenetic Technology on LFP of the Basal Ganglia Nucleus in Rotenone-Treated Rats

  2021cites this paper
• Attenuation of Hippocampal Evoked Potentials in vivo by Activation of GtACR2, an Optogenetic Chloride Channel

  2021influential citation
• Optogenetic approaches for understanding homeostatic and degenerative processes in Drosophila

  2021cites this paper
• New era of optogenetics: from the central to peripheral nervous system

  2020cites this paper
• Optogenetic inactivation of the entopeduncular nucleus improves forelimb akinesia in a Parkinson's disease model.

  2020cites this paper
• Animal Models for Parkinson’s Disease Research: Trends in the 2000s

  2019cites this paper